Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.330 | GeneticVariation | disease | BEFREE | In the present study, we report cases of two synchronous lung adenocarcinomas composed of two distinct pathological subtypes with different EGFR gene mutations: a homozygous deletion in exon 19 of the papillary adenocarcinoma subtype and a point mutation of L858R in exon 21 of the tubular adenocarcinoma. | 29090842 | 2018 | ||||
|
0.330 | Biomarker | disease | CTD_human | Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients. | 27720938 | 2016 | ||||
|
0.330 | AlteredExpression | disease | BEFREE | EGFR was expressed in 87 % of tubular adenocarcinoma and 48 % of IPMN lesions. | 23475261 | 2013 | ||||
|
0.330 | Biomarker | disease | CTD_human | MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib. | 22042947 | 2011 | ||||
|
0.330 | Biomarker | disease | CTD_human | Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trial. | 21541241 | 2011 | ||||
|
0.330 | Biomarker | disease | CTD_human | Co-activation of epidermal growth factor receptor and c-MET defines a distinct subset of lung adenocarcinomas. | 20934974 | 2010 | ||||
|
0.330 | GeneticVariation | disease | BEFREE | Herein, we report a case of 2 synchronous lung adenocarcinomas composed of 2 distinct pathological subtypes with different EGFR mutations: homozygous deletion in exon 19 in the papillary subtype of adenocarcinoma and a point mutation of L858R in exon 21 in the tubular adenocarcinoma. | 18186961 | 2007 | ||||
|
0.330 | Biomarker | disease | CTD_human | Mammary adenocarcinomas induced by medroxyprogesterone acetate: hormone dependence and EGF receptors of BALB/c in vivo sublines. | 2523869 | 1989 |